PG
RMD icon

Pendal Group’s ResMed RMD Stock Holding History

Pendal Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,700
Closed -$6.7M – 527
2022
Q3 		$6.7M Buy
+30,700
New +$6.99M 0.07% 125
2019
Q3 		– Sell
-4,440
Closed -$76.2K – 480
2019
Q2 		$76.2K Buy
+4,440
New +$492K ﹤0.01% 416
2018
Q4 		– Sell
-2,731
Closed -$315K – 469
2018
Q3 		$315K Buy
+2,731
New +$299K ﹤0.01% 393

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Pendal Group's RMD Position: Q4 2022 in Review

Pendal Group sold out of ResMed (RMD) in Q4 2022, closing a stake of 30,700 shares — an estimated $6.7M sold.

Pendal Group first reported a position in RMD in Q3 2018 and held it in 3 quarters. The position peaked at $6.7M in Q3 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Pendal Group reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Pendal Group sold 30,700 ResMed shares in Q4 2022, an estimated $6.7M.
  • Pendal Group first reported a position in ResMed in Q3 2018 and held it in 3 quarters.
  • Pendal Group's ResMed position peaked at $6.7M in Q3 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.